However, more research should be undertaken to identify the downstream genetic targets of KDM2A and KDM2B in AD, especially considering the contrary regulation of these modifiers observed in postmortem brain tissue from patients with AD. This evidence concerns the gene KDM2A and Alzheimer disease.